X-BIOTIX THERAPEUTICS
X-Biotix Therapeutics specializes in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) gram-negative pathogens to address the urgent and growing global threat of antibiotic resistance. It applies a multi-target strategy to generate a pipeline of effective antibiotics with inhibitory activity against a wide range of biological targets in essential pathways of gram-negative bacterial cells and which are also predicted to defeat known antibiotic resistance mechanisms. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
X-BIOTIX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.x-biotixrx.com
Total Employee:
1+
Status:
Active
Contact:
+1 781-419-6900
Email Addresses:
[email protected]
Total Funding:
7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.x-biotixrx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "X-Biotix Therapeutics"
X-Biotix Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 1 (781) 209-4413 X-Biotix Therapeutics specializes in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) gram-negative pathogens to address …See details»
X-Biotix Therapeutics Company Profile 2024: Valuation, …
Jun 25, 2019 X-Biotix Therapeutics General Information Description. Developer of novel small molecule antibiotic scaffolds intended to treat antibiotic resistance. The company's scaffolds apply a multi-target strategy to generate a pipeline of …See details»
www.x-biotixrx.com
Www.x-biotixrx.comSee details»
X-Biotix Therapeutics, Inc. - LinkedIn
X-Biotix Therapeutics, Inc. Biotechnology Research Waltham, Massachusetts 336 followers Discovering and developing first-in-class antibiotics to combat multi-drug resistant Gram …See details»
X-Biotix Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for X-Biotix Therapeutics, Inc. of Orinda, CA. Get the latest business insights from Dun & Bradstreet.See details»
X-Biotix Therapeutics Announces Change in Corporate Strategy
Apr 26, 2021 The World Health Organization predicts that by 2050, antimicrobial resistance could cause 10 million deaths each year, surpassing the projected number of deaths due to …See details»
X-Biotix - Company Profile - Tracxn
Nov 27, 2024 X-Biotix - Small molecule antibiotic scaffolds MDR gram negative pathogens. Raised a total funding of $13.4M over 2 rounds. Founded by John Mekalanos, Ramani …See details»
X-Biotix Therapeutics Company Profile - Craft
X-Biotix Therapeutics has 5 employees at their 1 location. See insights on X-Biotix Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
X-Biotix Therapeutics Announces Change in Corporate Strategy
Apr 26, 2021 X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of first-in-class antibiotic compounds targeting multi-drug-resistant …See details»
X-Biotix Therapeutics - Overview, News & Similar companies
Apr 21, 2020 X-Biotix Therapeutics contact info: Phone number: (781) 209-4413 Website: www.x-biotixrx.com What does X-Biotix Therapeutics do? X-Biotix is a discovery and …See details»
X-Biotix Therapeutics Announces Corporate Progress and …
Nov 13, 2019 About X-Biotix Therapeutics, Inc. X-Biotix is a discovery and development company, with a focus on delivering the next generation of antibiotics to combat multi-drug …See details»
X-Biotix Therapeutics, Inc. Strengthens Leadership Team with Key ...
May 30, 2019 WALTHAM, Mass.--(BUSINESS WIRE)-- X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of multiple novel antibiotic …See details»
X-Biotix Licenses Harvard Technology, Establishes Research ...
May 30, 2017 X-Biotix is a discovery, early preclinical-stage company that was spun out of X-Chem and incorporated in 2016, with a focus on delivering the next generation of antibiotics to …See details»
X-Biotix Therapeutics - Products, Competitors, Financials, …
X-Biotix Therapeutics is a biotechnology company that focuses on the development of novel antibiotic solutions, specifically targeting multi-drug resistant Gram-negative pathogens. Use …See details»
X-BIOTIX THERAPEUTICS ANNOUNCES CORPORATE PROGRESS …
Nov 13, 2019 A report by the World Health Organization predicts that by 2050, antibiotic resistance could cause 10 million deaths each year, surpassing the projected number of …See details»
X-Chem spin-off X-Biotix Therapeutics Completes $7 million Series …
For detailed information about X-Biotix please visit X-Biotix’s website at www.x-biotixrx.com About X-Chem’s DNA-Encoded (DEX™) Libraries and Platform X-Chem’s DEX drug discovery …See details»
X-Biotix Therapeutics Announces Appointment Of Michael W.
Apr 21, 2020 The World Health Organization predicts that by 2050, antimicrobial resistance could cause 10 million deaths each year, surpassing the projected number of deaths due to …See details»
Research programme: small molecule antibacterials - X-Biotix ...
X-Biotix therapeutics was developing novel antibiotic scaffolds with inhibitory activity against a wide range of biological targets in essential pathways ofSee details»
X-Biotix Therapeutics Licenses Harvard Technology ... - BioSpace
May 30, 2017 WALTHAM, Mass.--(BUSINESS WIRE)--X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of novel small molecule …See details»
X-Biotix Therapeutics, Inc. Strengthens Leadership Team with Key ...
May 30, 2019 A report recently released by the World Health Organization predicts that by 2050, antibiotic resistance could cause 10 million deaths each year, surpassing the projected …See details»